AI data platform drives diagnostics growth
Tempest (TEM) is a compelling AI-driven healthcare data platform with massive proprietary biological datasets and accelerating diagnostics revenue, but I won’t buy more because my biotech allocation is already too large.
Tempest is characterized as a compelling AI-driven healthcare data platform with massive proprietary biological datasets and accelerating diagnostics revenue. The bullish view is qualified only by portfolio allocation constraints, not by any fundamental concern.